Sezary Syndrome

Sezary Syndrome is a rare type of skin cancer called lymphoma. It causes a widespread rash that covers most of the body, intense itching, and swollen lymph nodes. It's also called Sezary's Lymphoma.

Condition

What people with Sezary Syndrome report

Every report comes from a Lived member, sent anonymously.

Have you tried Targretin (Bexarotene) for Sezary Syndrome?

NameHow it went

About Sezary Syndrome

What It Is

Sezary syndrome is a rare type of lymphoma, a cancer of the immune system, that affects the skin and the blood at the same time. It starts in T cells, white blood cells that normally help the body fight infection. In Sezary syndrome, abnormal T cells (called Sezary cells) build up in the skin, circulate in the bloodstream and often collect in the lymph nodes. Its hallmark is erythroderma: red, inflamed skin covering most or all of the body, often with scaling and peeling and an intense, persistent itch. The palms and soles may become thick and cracked, the lower eyelids can turn outward, and lymph nodes in the neck, armpits or groin are often enlarged. Sezary syndrome is one of the two main forms of cutaneous T-cell lymphoma, meaning a T-cell lymphoma that shows itself in the skin. The other, mycosis fungoides, usually begins as scattered patches and progresses slowly over years. Sezary syndrome involves the blood from the outset and generally behaves more aggressively. Occasionally, it develops in someone who first had mycosis fungoides.

Causes & Risk Factors

The cause of Sezary syndrome is not known. It is not contagious, and nothing a person did is known to bring it on. Researchers have found recurring genetic changes inside the lymphoma cells that help drive their growth, but what sets those changes in motion is unclear. It is diagnosed most often in adults over 50 and is more common in men. In the United States, cutaneous T-cell lymphomas are also diagnosed more often in Black patients. Ultraviolet light and some environmental exposures have been studied as possible contributors to cutaneous T-cell lymphoma in general, but none is an established cause of Sezary syndrome. Separate from what causes the disease, the damaged skin is easily colonized by Staphylococcus aureus, a common skin bacterium. This bacterium is suspected of fueling disease activity, so infection can make itching and redness worse and may make treatment less effective.

How It's Diagnosed

Sezary syndrome is often mistaken at first for severe eczema or psoriasis, because widespread red, itchy skin has many causes. Reaching a diagnosis can take time and usually involves a dermatologist or cancer specialist experienced with skin lymphomas. Blood tests are central. Flow cytometry, a test that identifies cells by the markers on their surface, can reveal an unusual population of T cells, for example T cells that have lost markers called CD7 or CD26. A Sezary cell count of 1,000 or more per microliter of blood signals a high level of lymphoma in the blood. A T-cell receptor gene test checks whether the abnormal cells all come from a single clone, which points to cancer rather than inflammation. Skin biopsies are taken as well, though in Sezary syndrome they can look surprisingly subtle, so more than one may be needed. Because it involves the blood, Sezary syndrome is staged as an advanced (stage IV) form of cutaneous T-cell lymphoma. Scans such as CT or PET, and sometimes a lymph node or bone marrow biopsy, show whether lymph nodes or internal organs are involved, which helps guide treatment.

Treatment Options

No standard treatment reliably cures Sezary syndrome, but treatment can bring the disease under control, sometimes for long periods, and ease the itch and skin inflammation. Because the lymphoma is in both the skin and the blood, treatment usually needs to work throughout the body, and it is best planned with a team experienced in cutaneous lymphoma. Standard multidrug chemotherapy is generally not a first choice, because its benefits tend to be short-lived. Extracorporeal photopheresis (ECP) is a common first treatment. Blood passes through a machine that separates out white blood cells, treats them with a light-sensitizing drug and ultraviolet light, and returns them to the body, which appears to stimulate an immune response against the lymphoma. It is generally well tolerated, but improvement is gradual, typically taking around six months, and about 60% of people respond. ECP is often combined with interferon, an immune-signaling medicine given by injection, or bexarotene, a vitamin A-related pill that requires regular blood tests because it commonly raises blood fats and lowers thyroid hormone. When the disease returns or does not respond, other options include mogamulizumab (Poteligeo), an antibody infusion that targets a protein on the lymphoma cells and works especially well on lymphoma in the blood. A skin rash is one of its common side effects, and it is often avoided shortly before a planned transplant because it can raise the risk of severe complications afterward. Romidepsin, a type of medicine called a histone deacetylase (HDAC) inhibitor, is another option. Total skin electron beam therapy, a form of radiation that treats the whole skin surface without reaching deeper organs, can relieve skin symptoms. Clinical trials are a common part of care. For selected people, an allogeneic stem cell transplant (using a donor's blood-forming cells) offers a chance of lasting remission because the donor's immune cells can attack the lymphoma. It carries serious risks, including graft-versus-host disease, in which donor cells attack the body, and death from treatment complications in a meaningful minority, and the lymphoma still returns in many people. It is weighed carefully with a transplant center. Skin care is part of treatment. Topical steroids relieve inflamed skin, though the skin in Sezary syndrome is fragile and topical treatments are used cautiously.

What to Expect

Sezary syndrome is usually a long-term illness managed with a sequence of treatments rather than a single course. Many people go through cycles in which a treatment works for a time, the disease becomes active again, and the team moves to another option or combines therapies. Responses are often partial, but even partial control can meaningfully reduce itch and improve sleep and comfort. The outlook is serious and varies widely. Studies of advanced cutaneous T-cell lymphoma have found median survival of roughly one to five years, with older age, a high level of LDH (lactate dehydrogenase, a blood marker of disease activity) and a previous diagnosis of mycosis fungoides linked to a less favorable course. Some people live much longer, particularly those who respond well to treatment, and median survival beyond eight years has been reported in people treated with ECP. Newer medicines may change these figures, but their effect on survival is not yet known. Daily life is often shaped by the skin. Constant itch, peeling and visible redness can disrupt sleep and weigh on mood, work and relationships, so supportive care for symptoms matters as much as treatment aimed at the lymphoma. Follow-up includes regular blood tests to track the abnormal cells, skin checks and sometimes scans. People with cutaneous T-cell lymphoma also have a higher rate of other cancers, including melanoma, so routine skin cancer checks are part of long-term care.

When to Seek Help

See a doctor, ideally a dermatologist, if red, itchy skin covers large areas of the body, keeps spreading, or does not improve with treatment for eczema or psoriasis, especially if lymph nodes are also enlarged. It is reasonable to ask whether blood tests for lymphoma are needed. If you have Sezary syndrome, contact your care team right away for fever or chills, or for skin that becomes more painful, hot, oozing or crusted, because skin infections are common and can spread into the blood. Report a new rash or a clear worsening of the skin during treatment promptly as well. Get emergency care if signs of infection come with confusion, rapid breathing, a racing heart, shortness of breath or clammy skin. These can signal sepsis, a life-threatening reaction to infection.

Questions to Ask Your Doctor

  1. 1.What do my blood tests show about how much lymphoma is in my blood, skin and lymph nodes, and how will we track it over time?
  2. 2.Which treatment do you recommend first, how will we know whether it is working, and how long should we give it?
  3. 3.What can we do to control the itch and protect my skin from infection?
  4. 4.Am I a candidate for a stem cell transplant or a clinical trial, and how would that affect the order of my treatments?
  5. 5.Should part of my care be coordinated with a center that specializes in cutaneous lymphoma?

Last reviewed • Oct 2026

Educational content, not medical advice.